nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Carmustine—melanoma	0.206	0.417	CbGbCtD
Tizanidine—CYP1A2—Vemurafenib—melanoma	0.163	0.33	CbGbCtD
Tizanidine—CYP1A2—Dacarbazine—melanoma	0.125	0.253	CbGbCtD
Tizanidine—NISCH—Paclitaxel—Docetaxel—melanoma	0.0112	1	CbGdCrCtD
Tizanidine—Renal failure—Carmustine—melanoma	0.0009	0.00259	CcSEcCtD
Tizanidine—Weight decreased—Temozolomide—melanoma	0.000897	0.00259	CcSEcCtD
Tizanidine—Neuropathy peripheral—Carmustine—melanoma	0.000897	0.00259	CcSEcCtD
Tizanidine—Hyperglycaemia—Temozolomide—melanoma	0.000895	0.00258	CcSEcCtD
Tizanidine—Pneumonia—Temozolomide—melanoma	0.00089	0.00257	CcSEcCtD
Tizanidine—Phlebitis—Docetaxel—melanoma	0.000886	0.00255	CcSEcCtD
Tizanidine—Depression—Temozolomide—melanoma	0.000882	0.00254	CcSEcCtD
Tizanidine—Hepatitis—Dactinomycin—melanoma	0.000878	0.00253	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000877	0.00253	CcSEcCtD
Tizanidine—Body temperature increased—Vemurafenib—melanoma	0.000872	0.00252	CcSEcCtD
Tizanidine—Pharyngitis—Dactinomycin—melanoma	0.000871	0.00251	CcSEcCtD
Tizanidine—Neuropathy peripheral—Temozolomide—melanoma	0.000867	0.0025	CcSEcCtD
Tizanidine—Deafness—Docetaxel—melanoma	0.000853	0.00246	CcSEcCtD
Tizanidine—Hepatic failure—Docetaxel—melanoma	0.000849	0.00245	CcSEcCtD
Tizanidine—Hepatobiliary disease—Temozolomide—melanoma	0.000836	0.00241	CcSEcCtD
Tizanidine—Alopecia—Bleomycin—melanoma	0.000832	0.0024	CcSEcCtD
Tizanidine—Erythema multiforme—Dactinomycin—melanoma	0.00083	0.00239	CcSEcCtD
Tizanidine—Sinusitis—Temozolomide—melanoma	0.00083	0.00239	CcSEcCtD
Tizanidine—Haemoglobin—Carmustine—melanoma	0.000826	0.00238	CcSEcCtD
Tizanidine—Haemorrhage—Carmustine—melanoma	0.000822	0.00237	CcSEcCtD
Tizanidine—Hallucination—Carmustine—melanoma	0.000817	0.00236	CcSEcCtD
Tizanidine—Hypersensitivity—Vemurafenib—melanoma	0.000813	0.00235	CcSEcCtD
Tizanidine—Connective tissue disorder—Carmustine—melanoma	0.000807	0.00233	CcSEcCtD
Tizanidine—Haemoglobin—Temozolomide—melanoma	0.000798	0.0023	CcSEcCtD
Tizanidine—Haemorrhage—Temozolomide—melanoma	0.000794	0.00229	CcSEcCtD
Tizanidine—Hepatitis—Temozolomide—melanoma	0.000794	0.00229	CcSEcCtD
Tizanidine—Asthenia—Vemurafenib—melanoma	0.000792	0.00228	CcSEcCtD
Tizanidine—Hallucination—Temozolomide—melanoma	0.00079	0.00228	CcSEcCtD
Tizanidine—Pharyngitis—Temozolomide—melanoma	0.000788	0.00227	CcSEcCtD
Tizanidine—Urinary tract disorder—Temozolomide—melanoma	0.000784	0.00226	CcSEcCtD
Tizanidine—Cardiac failure—Docetaxel—melanoma	0.000782	0.00226	CcSEcCtD
Tizanidine—Pruritus—Vemurafenib—melanoma	0.000781	0.00225	CcSEcCtD
Tizanidine—Connective tissue disorder—Temozolomide—melanoma	0.00078	0.00225	CcSEcCtD
Tizanidine—Urethral disorder—Temozolomide—melanoma	0.000778	0.00224	CcSEcCtD
Tizanidine—Alopecia—Dactinomycin—melanoma	0.000776	0.00224	CcSEcCtD
Tizanidine—Hyponatraemia—Docetaxel—melanoma	0.000766	0.00221	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000763	0.0022	CcSEcCtD
Tizanidine—Ill-defined disorder—Bleomycin—melanoma	0.00076	0.00219	CcSEcCtD
Tizanidine—Anaemia—Bleomycin—melanoma	0.000757	0.00218	CcSEcCtD
Tizanidine—Diarrhoea—Vemurafenib—melanoma	0.000755	0.00218	CcSEcCtD
Tizanidine—Migraine—Docetaxel—melanoma	0.000751	0.00217	CcSEcCtD
Tizanidine—Erythema multiforme—Temozolomide—melanoma	0.000751	0.00216	CcSEcCtD
Tizanidine—Tinnitus—Temozolomide—melanoma	0.00074	0.00213	CcSEcCtD
Tizanidine—Malaise—Bleomycin—melanoma	0.000739	0.00213	CcSEcCtD
Tizanidine—Cardiac disorder—Temozolomide—melanoma	0.000737	0.00212	CcSEcCtD
Tizanidine—Arrhythmia—Carmustine—melanoma	0.000734	0.00212	CcSEcCtD
Tizanidine—Leukopenia—Bleomycin—melanoma	0.000733	0.00212	CcSEcCtD
Tizanidine—Dizziness—Vemurafenib—melanoma	0.00073	0.0021	CcSEcCtD
Tizanidine—Alopecia—Carmustine—melanoma	0.000726	0.00209	CcSEcCtD
Tizanidine—Angiopathy—Temozolomide—melanoma	0.00072	0.00208	CcSEcCtD
Tizanidine—Mental disorder—Carmustine—melanoma	0.00072	0.00208	CcSEcCtD
Tizanidine—Immune system disorder—Temozolomide—melanoma	0.000717	0.00207	CcSEcCtD
Tizanidine—Mediastinal disorder—Temozolomide—melanoma	0.000716	0.00206	CcSEcCtD
Tizanidine—Ill-defined disorder—Dactinomycin—melanoma	0.000709	0.00204	CcSEcCtD
Tizanidine—Anaemia—Dactinomycin—melanoma	0.000706	0.00204	CcSEcCtD
Tizanidine—Liver function test abnormal—Docetaxel—melanoma	0.000705	0.00203	CcSEcCtD
Tizanidine—Vomiting—Vemurafenib—melanoma	0.000702	0.00202	CcSEcCtD
Tizanidine—Alopecia—Temozolomide—melanoma	0.000702	0.00202	CcSEcCtD
Tizanidine—Dry skin—Docetaxel—melanoma	0.0007	0.00202	CcSEcCtD
Tizanidine—Orthostatic hypotension—Docetaxel—melanoma	0.000697	0.00201	CcSEcCtD
Tizanidine—Rash—Vemurafenib—melanoma	0.000696	0.00201	CcSEcCtD
Tizanidine—Mental disorder—Temozolomide—melanoma	0.000696	0.00201	CcSEcCtD
Tizanidine—Dermatitis—Vemurafenib—melanoma	0.000695	0.00201	CcSEcCtD
Tizanidine—Back pain—Carmustine—melanoma	0.000692	0.002	CcSEcCtD
Tizanidine—Discomfort—Bleomycin—melanoma	0.000689	0.00199	CcSEcCtD
Tizanidine—Malaise—Dactinomycin—melanoma	0.000689	0.00199	CcSEcCtD
Tizanidine—Leukopenia—Dactinomycin—melanoma	0.000684	0.00197	CcSEcCtD
Tizanidine—Confusional state—Bleomycin—melanoma	0.000674	0.00194	CcSEcCtD
Tizanidine—Vision blurred—Carmustine—melanoma	0.000674	0.00194	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000673	0.00194	CcSEcCtD
Tizanidine—Tremor—Carmustine—melanoma	0.00067	0.00193	CcSEcCtD
Tizanidine—Oedema—Bleomycin—melanoma	0.000669	0.00193	CcSEcCtD
Tizanidine—Anaphylactic shock—Bleomycin—melanoma	0.000669	0.00193	CcSEcCtD
Tizanidine—Back pain—Temozolomide—melanoma	0.000669	0.00193	CcSEcCtD
Tizanidine—Infection—Bleomycin—melanoma	0.000664	0.00192	CcSEcCtD
Tizanidine—Anaemia—Carmustine—melanoma	0.000661	0.00191	CcSEcCtD
Tizanidine—Dysphagia—Docetaxel—melanoma	0.00066	0.0019	CcSEcCtD
Tizanidine—Agitation—Carmustine—melanoma	0.000657	0.0019	CcSEcCtD
Tizanidine—Nausea—Vemurafenib—melanoma	0.000656	0.00189	CcSEcCtD
Tizanidine—Thrombocytopenia—Bleomycin—melanoma	0.000655	0.00189	CcSEcCtD
Tizanidine—Vision blurred—Temozolomide—melanoma	0.000651	0.00188	CcSEcCtD
Tizanidine—Tremor—Temozolomide—melanoma	0.000648	0.00187	CcSEcCtD
Tizanidine—Discomfort—Dactinomycin—melanoma	0.000643	0.00185	CcSEcCtD
Tizanidine—Angina pectoris—Docetaxel—melanoma	0.000643	0.00185	CcSEcCtD
Tizanidine—Ill-defined disorder—Temozolomide—melanoma	0.000641	0.00185	CcSEcCtD
Tizanidine—Leukopenia—Carmustine—melanoma	0.00064	0.00185	CcSEcCtD
Tizanidine—Anaemia—Temozolomide—melanoma	0.000639	0.00184	CcSEcCtD
Tizanidine—Agitation—Temozolomide—melanoma	0.000635	0.00183	CcSEcCtD
Tizanidine—Hypotension—Bleomycin—melanoma	0.000625	0.0018	CcSEcCtD
Tizanidine—Oedema—Dactinomycin—melanoma	0.000624	0.0018	CcSEcCtD
Tizanidine—Malaise—Temozolomide—melanoma	0.000623	0.0018	CcSEcCtD
Tizanidine—Vertigo—Temozolomide—melanoma	0.000621	0.00179	CcSEcCtD
Tizanidine—Convulsion—Carmustine—melanoma	0.00062	0.00179	CcSEcCtD
Tizanidine—Infection—Dactinomycin—melanoma	0.00062	0.00179	CcSEcCtD
Tizanidine—Leukopenia—Temozolomide—melanoma	0.000619	0.00178	CcSEcCtD
Tizanidine—Hypertension—Carmustine—melanoma	0.000617	0.00178	CcSEcCtD
Tizanidine—Thrombocytopenia—Dactinomycin—melanoma	0.000611	0.00176	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000609	0.00176	CcSEcCtD
Tizanidine—Anxiety—Carmustine—melanoma	0.000607	0.00175	CcSEcCtD
Tizanidine—Paraesthesia—Bleomycin—melanoma	0.0006	0.00173	CcSEcCtD
Tizanidine—Convulsion—Temozolomide—melanoma	0.000599	0.00173	CcSEcCtD
Tizanidine—Weight decreased—Docetaxel—melanoma	0.000597	0.00172	CcSEcCtD
Tizanidine—Hypertension—Temozolomide—melanoma	0.000597	0.00172	CcSEcCtD
Tizanidine—Dyspnoea—Bleomycin—melanoma	0.000596	0.00172	CcSEcCtD
Tizanidine—Pneumonia—Docetaxel—melanoma	0.000592	0.00171	CcSEcCtD
Tizanidine—Confusional state—Carmustine—melanoma	0.000589	0.0017	CcSEcCtD
Tizanidine—Arthralgia—Temozolomide—melanoma	0.000588	0.0017	CcSEcCtD
Tizanidine—Anxiety—Temozolomide—melanoma	0.000586	0.00169	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000584	0.00169	CcSEcCtD
Tizanidine—Oedema—Carmustine—melanoma	0.000584	0.00168	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000583	0.00168	CcSEcCtD
Tizanidine—Discomfort—Temozolomide—melanoma	0.000581	0.00168	CcSEcCtD
Tizanidine—Infection—Carmustine—melanoma	0.00058	0.00167	CcSEcCtD
Tizanidine—Acute coronary syndrome—Docetaxel—melanoma	0.00058	0.00167	CcSEcCtD
Tizanidine—Renal failure—Docetaxel—melanoma	0.000578	0.00167	CcSEcCtD
Tizanidine—Neuropathy peripheral—Docetaxel—melanoma	0.000577	0.00166	CcSEcCtD
Tizanidine—Myocardial infarction—Docetaxel—melanoma	0.000577	0.00166	CcSEcCtD
Tizanidine—Dry mouth—Temozolomide—melanoma	0.000575	0.00166	CcSEcCtD
Tizanidine—Jaundice—Docetaxel—melanoma	0.000573	0.00165	CcSEcCtD
Tizanidine—Conjunctivitis—Docetaxel—melanoma	0.000572	0.00165	CcSEcCtD
Tizanidine—Thrombocytopenia—Carmustine—melanoma	0.000571	0.00165	CcSEcCtD
Tizanidine—Tachycardia—Carmustine—melanoma	0.00057	0.00164	CcSEcCtD
Tizanidine—Confusional state—Temozolomide—melanoma	0.000569	0.00164	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000568	0.00164	CcSEcCtD
Tizanidine—Anaphylactic shock—Temozolomide—melanoma	0.000564	0.00163	CcSEcCtD
Tizanidine—Oedema—Temozolomide—melanoma	0.000564	0.00163	CcSEcCtD
Tizanidine—Infection—Temozolomide—melanoma	0.00056	0.00162	CcSEcCtD
Tizanidine—Hepatobiliary disease—Docetaxel—melanoma	0.000556	0.0016	CcSEcCtD
Tizanidine—Nervous system disorder—Temozolomide—melanoma	0.000553	0.0016	CcSEcCtD
Tizanidine—Thrombocytopenia—Temozolomide—melanoma	0.000552	0.00159	CcSEcCtD
Tizanidine—Feeling abnormal—Bleomycin—melanoma	0.000551	0.00159	CcSEcCtD
Tizanidine—Agranulocytosis—Docetaxel—melanoma	0.000549	0.00158	CcSEcCtD
Tizanidine—Skin disorder—Temozolomide—melanoma	0.000548	0.00158	CcSEcCtD
Tizanidine—Hypotension—Carmustine—melanoma	0.000545	0.00157	CcSEcCtD
Tizanidine—Hyperhidrosis—Temozolomide—melanoma	0.000545	0.00157	CcSEcCtD
Tizanidine—Fatigue—Dactinomycin—melanoma	0.000538	0.00155	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000532	0.00153	CcSEcCtD
Tizanidine—Urticaria—Bleomycin—melanoma	0.000531	0.00153	CcSEcCtD
Tizanidine—Haemoglobin—Docetaxel—melanoma	0.000531	0.00153	CcSEcCtD
Tizanidine—Rhinitis—Docetaxel—melanoma	0.000529	0.00153	CcSEcCtD
Tizanidine—Body temperature increased—Bleomycin—melanoma	0.000529	0.00152	CcSEcCtD
Tizanidine—Hepatitis—Docetaxel—melanoma	0.000528	0.00152	CcSEcCtD
Tizanidine—Haemorrhage—Docetaxel—melanoma	0.000528	0.00152	CcSEcCtD
Tizanidine—Paraesthesia—Carmustine—melanoma	0.000524	0.00151	CcSEcCtD
Tizanidine—Pharyngitis—Docetaxel—melanoma	0.000524	0.00151	CcSEcCtD
Tizanidine—Urinary tract disorder—Docetaxel—melanoma	0.000521	0.0015	CcSEcCtD
Tizanidine—Dyspnoea—Carmustine—melanoma	0.00052	0.0015	CcSEcCtD
Tizanidine—Somnolence—Carmustine—melanoma	0.000519	0.0015	CcSEcCtD
Tizanidine—Connective tissue disorder—Docetaxel—melanoma	0.000519	0.0015	CcSEcCtD
Tizanidine—Urethral disorder—Docetaxel—melanoma	0.000518	0.00149	CcSEcCtD
Tizanidine—Feeling abnormal—Dactinomycin—melanoma	0.000514	0.00148	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000514	0.00148	CcSEcCtD
Tizanidine—Gastrointestinal pain—Dactinomycin—melanoma	0.00051	0.00147	CcSEcCtD
Tizanidine—Paraesthesia—Temozolomide—melanoma	0.000506	0.00146	CcSEcCtD
Tizanidine—Dyspnoea—Temozolomide—melanoma	0.000503	0.00145	CcSEcCtD
Tizanidine—Somnolence—Temozolomide—melanoma	0.000501	0.00145	CcSEcCtD
Tizanidine—Erythema multiforme—Docetaxel—melanoma	0.000499	0.00144	CcSEcCtD
Tizanidine—Constipation—Carmustine—melanoma	0.000499	0.00144	CcSEcCtD
Tizanidine—Dyspepsia—Temozolomide—melanoma	0.000497	0.00143	CcSEcCtD
Tizanidine—Abdominal pain—Dactinomycin—melanoma	0.000493	0.00142	CcSEcCtD
Tizanidine—Body temperature increased—Dactinomycin—melanoma	0.000493	0.00142	CcSEcCtD
Tizanidine—Hypersensitivity—Bleomycin—melanoma	0.000493	0.00142	CcSEcCtD
Tizanidine—Cardiac disorder—Docetaxel—melanoma	0.00049	0.00141	CcSEcCtD
Tizanidine—Fatigue—Temozolomide—melanoma	0.000486	0.0014	CcSEcCtD
Tizanidine—Constipation—Temozolomide—melanoma	0.000482	0.00139	CcSEcCtD
Tizanidine—Feeling abnormal—Carmustine—melanoma	0.000481	0.00139	CcSEcCtD
Tizanidine—Asthenia—Bleomycin—melanoma	0.00048	0.00138	CcSEcCtD
Tizanidine—Angiopathy—Docetaxel—melanoma	0.000479	0.00138	CcSEcCtD
Tizanidine—Gastrointestinal pain—Carmustine—melanoma	0.000477	0.00138	CcSEcCtD
Tizanidine—Immune system disorder—Docetaxel—melanoma	0.000477	0.00138	CcSEcCtD
Tizanidine—Mediastinal disorder—Docetaxel—melanoma	0.000476	0.00137	CcSEcCtD
Tizanidine—Pruritus—Bleomycin—melanoma	0.000473	0.00136	CcSEcCtD
Tizanidine—Arrhythmia—Docetaxel—melanoma	0.000472	0.00136	CcSEcCtD
Tizanidine—Alopecia—Docetaxel—melanoma	0.000467	0.00135	CcSEcCtD
Tizanidine—Feeling abnormal—Temozolomide—melanoma	0.000465	0.00134	CcSEcCtD
Tizanidine—Mental disorder—Docetaxel—melanoma	0.000463	0.00133	CcSEcCtD
Tizanidine—Abdominal pain—Carmustine—melanoma	0.000461	0.00133	CcSEcCtD
Tizanidine—Body temperature increased—Carmustine—melanoma	0.000461	0.00133	CcSEcCtD
Tizanidine—Gastrointestinal pain—Temozolomide—melanoma	0.000461	0.00133	CcSEcCtD
Tizanidine—Hypersensitivity—Dactinomycin—melanoma	0.000459	0.00133	CcSEcCtD
Tizanidine—Urticaria—Temozolomide—melanoma	0.000448	0.00129	CcSEcCtD
Tizanidine—Asthenia—Dactinomycin—melanoma	0.000447	0.00129	CcSEcCtD
Tizanidine—Body temperature increased—Temozolomide—melanoma	0.000446	0.00129	CcSEcCtD
Tizanidine—Abdominal pain—Temozolomide—melanoma	0.000446	0.00129	CcSEcCtD
Tizanidine—Back pain—Docetaxel—melanoma	0.000445	0.00128	CcSEcCtD
Tizanidine—Muscle spasms—Docetaxel—melanoma	0.000442	0.00127	CcSEcCtD
Tizanidine—Hypersensitivity—Carmustine—melanoma	0.00043	0.00124	CcSEcCtD
Tizanidine—Diarrhoea—Dactinomycin—melanoma	0.000427	0.00123	CcSEcCtD
Tizanidine—Vomiting—Bleomycin—melanoma	0.000425	0.00123	CcSEcCtD
Tizanidine—Anaemia—Docetaxel—melanoma	0.000425	0.00123	CcSEcCtD
Tizanidine—Rash—Bleomycin—melanoma	0.000422	0.00122	CcSEcCtD
Tizanidine—Dermatitis—Bleomycin—melanoma	0.000421	0.00121	CcSEcCtD
Tizanidine—Asthenia—Carmustine—melanoma	0.000419	0.00121	CcSEcCtD
Tizanidine—Hypersensitivity—Temozolomide—melanoma	0.000416	0.0012	CcSEcCtD
Tizanidine—Syncope—Docetaxel—melanoma	0.000412	0.00119	CcSEcCtD
Tizanidine—Leukopenia—Docetaxel—melanoma	0.000411	0.00119	CcSEcCtD
Tizanidine—Asthenia—Temozolomide—melanoma	0.000405	0.00117	CcSEcCtD
Tizanidine—Loss of consciousness—Docetaxel—melanoma	0.000404	0.00117	CcSEcCtD
Tizanidine—Diarrhoea—Carmustine—melanoma	0.000399	0.00115	CcSEcCtD
Tizanidine—Pruritus—Temozolomide—melanoma	0.000399	0.00115	CcSEcCtD
Tizanidine—Convulsion—Docetaxel—melanoma	0.000398	0.00115	CcSEcCtD
Tizanidine—Nausea—Bleomycin—melanoma	0.000397	0.00115	CcSEcCtD
Tizanidine—Hypertension—Docetaxel—melanoma	0.000397	0.00114	CcSEcCtD
Tizanidine—Vomiting—Dactinomycin—melanoma	0.000397	0.00114	CcSEcCtD
Tizanidine—Rash—Dactinomycin—melanoma	0.000393	0.00113	CcSEcCtD
Tizanidine—Arthralgia—Docetaxel—melanoma	0.000391	0.00113	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000389	0.00112	CcSEcCtD
Tizanidine—Dizziness—Carmustine—melanoma	0.000386	0.00111	CcSEcCtD
Tizanidine—Diarrhoea—Temozolomide—melanoma	0.000386	0.00111	CcSEcCtD
Tizanidine—Dry mouth—Docetaxel—melanoma	0.000383	0.0011	CcSEcCtD
Tizanidine—Confusional state—Docetaxel—melanoma	0.000378	0.00109	CcSEcCtD
Tizanidine—Anaphylactic shock—Docetaxel—melanoma	0.000375	0.00108	CcSEcCtD
Tizanidine—Oedema—Docetaxel—melanoma	0.000375	0.00108	CcSEcCtD
Tizanidine—Dizziness—Temozolomide—melanoma	0.000373	0.00108	CcSEcCtD
Tizanidine—Infection—Docetaxel—melanoma	0.000373	0.00107	CcSEcCtD
Tizanidine—Vomiting—Carmustine—melanoma	0.000371	0.00107	CcSEcCtD
Tizanidine—Nausea—Dactinomycin—melanoma	0.00037	0.00107	CcSEcCtD
Tizanidine—Shock—Docetaxel—melanoma	0.000369	0.00106	CcSEcCtD
Tizanidine—Rash—Carmustine—melanoma	0.000368	0.00106	CcSEcCtD
Tizanidine—Nervous system disorder—Docetaxel—melanoma	0.000368	0.00106	CcSEcCtD
Tizanidine—Dermatitis—Carmustine—melanoma	0.000368	0.00106	CcSEcCtD
Tizanidine—Thrombocytopenia—Docetaxel—melanoma	0.000367	0.00106	CcSEcCtD
Tizanidine—Tachycardia—Docetaxel—melanoma	0.000366	0.00106	CcSEcCtD
Tizanidine—Skin disorder—Docetaxel—melanoma	0.000364	0.00105	CcSEcCtD
Tizanidine—Vomiting—Temozolomide—melanoma	0.000359	0.00103	CcSEcCtD
Tizanidine—Rash—Temozolomide—melanoma	0.000356	0.00103	CcSEcCtD
Tizanidine—Dermatitis—Temozolomide—melanoma	0.000355	0.00102	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—melanoma	0.000351	0.00101	CcSEcCtD
Tizanidine—Nausea—Carmustine—melanoma	0.000347	0.001	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000342	0.000986	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—melanoma	0.000337	0.000971	CcSEcCtD
Tizanidine—Nausea—Temozolomide—melanoma	0.000335	0.000966	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—melanoma	0.000334	0.000964	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—melanoma	0.000333	0.000962	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—melanoma	0.00033	0.000952	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—melanoma	0.000323	0.000933	CcSEcCtD
Tizanidine—Constipation—Docetaxel—melanoma	0.000321	0.000925	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—melanoma	0.000309	0.000891	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—melanoma	0.000307	0.000885	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—melanoma	0.000297	0.000855	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—melanoma	0.000297	0.000855	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—melanoma	0.000276	0.000797	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—melanoma	0.000269	0.000776	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—melanoma	0.000265	0.000765	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—melanoma	0.000257	0.00074	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—melanoma	0.000248	0.000715	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—melanoma	0.000239	0.000688	CcSEcCtD
Tizanidine—Rash—Docetaxel—melanoma	0.000237	0.000682	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—melanoma	0.000236	0.000681	CcSEcCtD
Tizanidine—Nausea—Docetaxel—melanoma	0.000223	0.000643	CcSEcCtD
Tizanidine—ADRA2A—Signaling Pathways—AKT3—melanoma	2.59e-05	0.000175	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—IL2—melanoma	2.58e-05	0.000174	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—E2F1—melanoma	2.57e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CB—melanoma	2.56e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK1—melanoma	2.54e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDGFRA—melanoma	2.54e-05	0.000171	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ITGB3—melanoma	2.51e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCA—melanoma	2.51e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL2—melanoma	2.51e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HRAS—melanoma	2.51e-05	0.00017	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—VCAN—melanoma	2.51e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TERT—melanoma	2.5e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAC1—melanoma	2.5e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SPP1—melanoma	2.47e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAP2K2—melanoma	2.46e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—melanoma	2.46e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PRKCA—melanoma	2.44e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ERCC2—melanoma	2.42e-05	0.000164	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS1—melanoma	2.4e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—melanoma	2.4e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAP2K1—melanoma	2.4e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—S100B—melanoma	2.4e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—melanoma	2.39e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—melanoma	2.38e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—melanoma	2.37e-05	0.00016	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.37e-05	0.00016	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—melanoma	2.36e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2—melanoma	2.35e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TERT—melanoma	2.34e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAC1—melanoma	2.33e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB4—melanoma	2.29e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—melanoma	2.29e-05	0.000155	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.29e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—melanoma	2.29e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—melanoma	2.27e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN2B—melanoma	2.27e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—melanoma	2.24e-05	0.000151	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—melanoma	2.22e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—melanoma	2.2e-05	0.000149	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FN1—melanoma	2.2e-05	0.000149	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD86—melanoma	2.2e-05	0.000148	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—melanoma	2.2e-05	0.000148	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDN1—melanoma	2.18e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH1—melanoma	2.16e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—melanoma	2.14e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—melanoma	2.13e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CSF2—melanoma	2.13e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF1—melanoma	2.13e-05	0.000144	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP17A1—melanoma	2.11e-05	0.000143	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CD80—melanoma	2.11e-05	0.000143	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—melanoma	2.11e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APC—melanoma	2.11e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KIT—melanoma	2.11e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—NRAS—melanoma	2.11e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2—melanoma	2.1e-05	0.000142	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.09e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—E2F1—melanoma	2.09e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGF—melanoma	2.08e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	2.08e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—melanoma	2.07e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDGFRA—melanoma	2.06e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FN1—melanoma	2.06e-05	0.000139	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.06e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—melanoma	2.04e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ITGB3—melanoma	2.04e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCA—melanoma	2.04e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HRAS—melanoma	2.04e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK3—melanoma	2.02e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH1—melanoma	2.01e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SPP1—melanoma	2e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAP2K2—melanoma	2e-05	0.000135	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNA11—melanoma	2e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—melanoma	1.99e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BRAF—melanoma	1.98e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CD80—melanoma	1.97e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—melanoma	1.97e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APC—melanoma	1.97e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KIT—melanoma	1.97e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—NRAS—melanoma	1.97e-05	0.000133	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—FASN—melanoma	1.95e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGF—melanoma	1.95e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—melanoma	1.93e-05	0.00013	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC5A5—melanoma	1.92e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK1—melanoma	1.92e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—melanoma	1.92e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—melanoma	1.91e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2—melanoma	1.91e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TERT—melanoma	1.9e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAC1—melanoma	1.89e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK3—melanoma	1.89e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAP2K1—melanoma	1.87e-05	0.000126	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD44—melanoma	1.86e-05	0.000125	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNAQ—melanoma	1.86e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—melanoma	1.85e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BRAF—melanoma	1.85e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—melanoma	1.85e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	1.84e-05	0.000124	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.82e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—melanoma	1.82e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—melanoma	1.82e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—melanoma	1.8e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—melanoma	1.8e-05	0.000122	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.8e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK1—melanoma	1.8e-05	0.000121	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—melanoma	1.79e-05	0.000121	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—melanoma	1.79e-05	0.000121	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1B1—melanoma	1.78e-05	0.00012	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGF2—melanoma	1.78e-05	0.00012	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAP2K1—melanoma	1.74e-05	0.000118	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—melanoma	1.74e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—melanoma	1.73e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—melanoma	1.72e-05	0.000116	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—melanoma	1.7e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—melanoma	1.68e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FN1—melanoma	1.67e-05	0.000113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	1.67e-05	0.000113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MDM2—melanoma	1.66e-05	0.000112	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—melanoma	1.66e-05	0.000112	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF2—melanoma	1.66e-05	0.000112	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB2—melanoma	1.64e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH1—melanoma	1.64e-05	0.00011	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—melanoma	1.62e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD80—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KIT—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APC—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—NRAS—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGF—melanoma	1.58e-05	0.000107	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.57e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTEN—melanoma	1.56e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—melanoma	1.56e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—melanoma	1.55e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MDM2—melanoma	1.55e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HRAS—melanoma	1.54e-05	0.000104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK3—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB2—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1B—melanoma	1.52e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—melanoma	1.51e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BRAF—melanoma	1.5e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—melanoma	1.49e-05	0.0001	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2—melanoma	1.48e-05	0.0001	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—melanoma	1.48e-05	9.97e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—melanoma	1.47e-05	9.9e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCB1—melanoma	1.47e-05	9.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—melanoma	1.47e-05	9.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	1.46e-05	9.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—melanoma	1.46e-05	9.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—melanoma	1.45e-05	9.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—melanoma	1.45e-05	9.79e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—melanoma	1.45e-05	9.77e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HRAS—melanoma	1.44e-05	9.73e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	1.43e-05	9.67e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1B—melanoma	1.42e-05	9.56e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	1.42e-05	9.56e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	1.41e-05	9.5e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—melanoma	1.4e-05	9.48e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—melanoma	1.4e-05	9.46e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	1.4e-05	9.45e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTEN—melanoma	1.4e-05	9.43e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	1.39e-05	9.4e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFKB1—melanoma	1.39e-05	9.38e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—melanoma	1.39e-05	9.37e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2—melanoma	1.39e-05	9.36e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—melanoma	1.38e-05	9.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—melanoma	1.38e-05	9.3e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—melanoma	1.36e-05	9.2e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—melanoma	1.35e-05	9.12e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PRKCA—melanoma	1.35e-05	9.1e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF2—melanoma	1.35e-05	9.09e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CTNNB1—melanoma	1.34e-05	9.03e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ERCC2—melanoma	1.34e-05	9.03e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—melanoma	1.31e-05	8.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1A—melanoma	1.31e-05	8.82e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTEN—melanoma	1.3e-05	8.8e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFKB1—melanoma	1.3e-05	8.76e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—melanoma	1.27e-05	8.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTEN—melanoma	1.27e-05	8.55e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	1.27e-05	8.54e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—melanoma	1.26e-05	8.51e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MDM2—melanoma	1.26e-05	8.51e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—melanoma	1.25e-05	8.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NRAS—melanoma	1.25e-05	8.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB2—melanoma	1.24e-05	8.39e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	1.23e-05	8.28e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK3—melanoma	1.19e-05	8.05e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—melanoma	1.18e-05	7.95e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—melanoma	1.18e-05	7.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HRAS—melanoma	1.17e-05	7.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—melanoma	1.17e-05	7.87e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NRAS—melanoma	1.16e-05	7.86e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—melanoma	1.16e-05	7.83e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	1.15e-05	7.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	1.14e-05	7.68e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK1—melanoma	1.14e-05	7.66e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—melanoma	1.14e-05	7.66e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—melanoma	1.13e-05	7.61e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2—melanoma	1.13e-05	7.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—melanoma	1.12e-05	7.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK3—melanoma	1.11e-05	7.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	7.48e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—melanoma	1.1e-05	7.43e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—melanoma	1.1e-05	7.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	1.09e-05	7.34e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—melanoma	1.08e-05	7.32e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—melanoma	1.07e-05	7.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—melanoma	1.07e-05	7.19e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	1.06e-05	7.17e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK1—melanoma	1.06e-05	7.16e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—melanoma	1.06e-05	7.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTEN—melanoma	1.06e-05	7.15e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—melanoma	1.06e-05	7.13e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFKB1—melanoma	1.05e-05	7.12e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—melanoma	1.03e-05	6.98e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—melanoma	1.02e-05	6.88e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—melanoma	1e-05	6.76e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	9.85e-06	6.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—melanoma	9.57e-06	6.46e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—melanoma	9.53e-06	6.43e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—melanoma	9.48e-06	6.4e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NRAS—melanoma	9.45e-06	6.38e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—melanoma	9.29e-06	6.27e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	9.2e-06	6.21e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—melanoma	9.17e-06	6.19e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HRAS—melanoma	9.11e-06	6.15e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK3—melanoma	9.05e-06	6.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—melanoma	8.99e-06	6.07e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—melanoma	8.94e-06	6.03e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—melanoma	8.9e-06	6.01e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—melanoma	8.8e-06	5.94e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—melanoma	8.72e-06	5.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK1—melanoma	8.61e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—melanoma	8.61e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HRAS—melanoma	8.51e-06	5.75e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—melanoma	8.15e-06	5.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—melanoma	8.14e-06	5.49e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—melanoma	8.09e-06	5.46e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—melanoma	8.05e-06	5.43e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—melanoma	8.02e-06	5.41e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—melanoma	7.52e-06	5.07e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	7.47e-06	5.05e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—melanoma	7.3e-06	4.93e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—melanoma	7.23e-06	4.88e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTEN—melanoma	6.99e-06	4.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRAS—melanoma	6.91e-06	4.67e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—melanoma	6.62e-06	4.47e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—melanoma	6.11e-06	4.12e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—melanoma	4.93e-06	3.33e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—melanoma	4.03e-06	2.72e-05	CbGpPWpGaD
